type 1 (monoclonal) cryoglobulinemia
Jump to navigation
Jump to search
Etiology
- multiple myeloma
- Waldenstrom's macroglobulinemia
- MGUS[2]
- B-cell non-Hodgkin's lymphoma, chronic lymphocytic leukemia[2]
- Sjogren's syndrome
- not strongly associated with hepatitis C
Pathology
- aggregates of a single monoclonal immunoglobulin
- type-1 cryoglobulins generally do NOT activate complement
- symptoms are generally related to hyperviscosity
- ischemic ulceration from occlusion of arterioles & venules by precipitated immune complexes
Clinical manifestations
- patients generally asymptomatic
- headaches
- visual disturbances
- nosebleeds
- Raynaud's phenomenon 40%
- skin ulcerations
- vasculitis is uncommon (less common than types 2 & 3)
- acrocyanosis 15%
- digital ischemia, distal necrosis 40%
- livedo reticularis
Laboratory
- cryoglobulins in serum/plasma
- trace amounts of cryoglobulins may be found in normal individuals
- serum protein electrophoresis & immunofixation electrophoresis
- rheumatoid factor (RF) is negative
- serum complement C3 in serum is generally low
- serum complement C4 in serum is generally low
Management
- therapy directed at underlying disease
- hyperviscosity responds to plasmapheresis
More general terms
Additional terms
References
- ↑ Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 849
- ↑ 2.0 2.1 2.2 2.3 Medical Knowledge Self Assessment Program (MKSAP) 11, 17, 18, 19. American College of Physicians, Philadelphia 1998, 2015, 2018, 2022.
- ↑ Brahn E, Scoville CD Biochemical markers of disease activity. Baillieres Clin Rheumatol 1988 2:153 PMID: https://www.ncbi.nlm.nih.gov/pubmed/2458192